Your search for ganciclovir returned 21 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Older than 2 years remove

Your search for ganciclovir returned 21 results

Sort Results:

Relevant Recent

Endo announced the launch of Valganciclovir Tablets, the first generic version of Roche’s Valcyte to be available in the U.S.

Endo announced that Qualitest, its subsidiary, has received final approval from the Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Valganciclovir Tablets, the generic version of Roche’s Valcyte.


This CME/CEU activity is designed to give clinicians a better understanding of the pharmacology, indications, contraindications, benefits/risk and clinical trials data of a broad spectrum of new agents and those that have been granted a new indication.


The FDA has notified healthcare professionals of new pediatric dosing recommendations for Valcyte (valganciclovir hydrochloride, from Roche) tablets and oral solution.


The FDA has approved Zirgan (ganciclovir ophthalmic gel, from Sirion Therapeutics) for the treatment of acute herpetic keratitis (dendritic ulcers).